Chargement en cours...

Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort study

BACKGROUND: Studies have shown that erythropoietin-stimulating agents (ESAs) protect mice against the development of diabetes through direct effects on pancreatic ß cells. However, the effect of ESAs on the incidence of diabetes in humans has not been well studied. It is unknown whether exposure to...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Can J Kidney Health Dis
Auteurs principaux: Montada-Atin, Tess, Choi, Diana, Woo, Minna, Retnakaran, Ravi, Huang, Michael, Prasad, G. V. Ramesh, Zaltzman, Jeffrey S.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4845385/
https://ncbi.nlm.nih.gov/pubmed/27119016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40697-016-0114-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!